MAI Capital Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

MAI Capital Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.06M	Buy	31,119 +2,606	+9%	+$153K	0.01%	695
2026 Q1	$1.54M	Sell	28,513 -1,235	-4%	-$68.8K	0.01%	650
2025 Q4	$1.67M	Sell	29,748 -540	-2%	-$28K	0.01%	612
2025 Q3	$1.45M	Sell	30,288 -5,797	-16%	-$259K	0.01%	608
2025 Q2	$1.46M	Sell	36,085 -1,388	-4%	-$55.8K	0.01%	563
2025 Q1	$1.64M	Sell	37,473 -215	-0.6%	-$9.49K	0.01%	518
2024 Q4	$1.62M	Sell	37,688 -389	-1%	-$17.7K	0.01%	518
2024 Q3	$1.69M	Sell	38,077 -720	-2%	-$30.8K	0.02%	427
2024 Q2	$1.54M	Sell	38,797 -1,171	-3%	-$47.4K	0.02%	470
2024 Q1	$1.72M	Buy	39,968 +13	+0%	+$560	0.02%	436
2023 Q4	$1.66M	Sell	39,955 -4,238	-10%	-$161K	0.02%	357
2023 Q3	$1.76M	Sell	44,193 -4,239	-9%	-$179K	0.03%	329
2023 Q2	$1.99M	Sell	48,432 -537	-1%	-$22.2K	0.03%	304
2023 Q1	$2.01M	Sell	48,969 -772	-2%	-$32.4K	0.03%	290
2022 Q4	$2.04M	Sell	49,741 -390	-0.8%	-$16.2K	0.03%	289
2022 Q3	$2.01M	Sell	50,131 -1,200	-2%	-$51.3K	0.04%	256
2022 Q2	$2.16M	Sell	51,331 -956	-2%	-$40.1K	0.04%	241
2022 Q1	$2.37M	Sell	52,287 -332	-0.6%	-$14.6K	0.04%	243
2021 Q4	$2.43M	Buy	+52,619	New	+$2.49M	0.04%	247

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Evelyn Partners London $46.9B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MAI Capital Management's XPH Position: Q2 2026 in Review

MAI Capital Management increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 9.1% in Q2 2026, buying an estimated $153K and bringing the position to 31,119 shares worth $2.06M. The position accounts for 0.01% of the portfolio, ranked #695.

MAI Capital Management first reported a position in XPH in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.43M in Q4 2021. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

MAI Capital Management held 31,119 shares of State Street SPDR S&P Pharmaceuticals ETF worth $2.06M as of Q2 2026.
MAI Capital Management bought 2,606 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $153K.
State Street SPDR S&P Pharmaceuticals ETF made up 0.01% of MAI Capital Management's portfolio in Q2 2026, its #695 holding.
MAI Capital Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2021 and has held it in 19 quarters since.
MAI Capital Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $2.43M in Q4 2021.
93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.